SINGAPORE, January 7, 2026 — EUDA Health Holdings Limited (NASDAQ: EUDA), referred to as “EUDA” or “the Company”, is a Singapore-headquartered non-invasive healthcare provider operating in Asia with a focus on Singapore, Malaysia, and China. Today, the Company announced that it has entered into an amendment (the “Warrant Amendment”) to its previously disclosed warrant agreement with Streeterville Capital, LLC (“Streeterville Capital”).
Background on the Original Warrant Transaction
As previously communicated, on November 26, 2025, EUDA entered into a securities purchase agreement with Streeterville Capital—a Utah-based limited liability company—to issue a warrant (the “Warrant”) exercisable for up to 2,000,000 newly issued ordinary shares of EUDA at an aggregate purchase price of US$100,000. The Warrant was issued on December 4, 2025. The offer and sale of the Warrant and the underlying Warrant Shares were conducted pursuant to a prospectus supplement dated December 4, 2025, which forms part of a Form F-3 registration statement (File No. 333-282723). This registration statement was filed with the Securities and Exchange Commission on October 18, 2024 and declared effective on November 4, 2024. The Warrant may be exercised for cash over a 90-day period (the “Cash Exercise Period”) from its issuance date, unless extended by both parties. Two weeks after the Cash Exercise Period expires, Streeterville Capital will automatically be deemed to have executed a “cashless” exercise of the Warrant, and the Company will be required to issue one (1) ordinary share to Streeterville Capital for every ten (10) outstanding Warrant Shares, with no additional consideration.
Summary of Amended Terms
On December 16, 2025, EUDA and Streeterville Capital entered into the Warrant Amendment to implement two changes: (i) reduce the Warrant’s exercise price from US$6.00 per share to US$4.00 per share, and (ii) lower the minimum closing price required to trigger a “Forced Exercise” (as defined in the Warrant) from US$7.50 to US$6.00. All other terms of the Warrant remain unchanged.
About EUDA Health Holdings Limited
EUDA Health Holdings Limited (NASDAQ: EUDA) is a leading Singapore-based non-invasive healthcare provider in Asia, focusing on Singapore, Malaysia, and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across the region, which is experiencing significant demographic shifts as more than 30% of its population ages rapidly. By offering innovative, accessible, and science-backed health solutions, EUDA is positioned to lead the transformation of regional healthcare from reactive medical treatment to proactive, longevity-focused care. EUDA also operates a Singapore-based property management business.
Forward-Looking Statements
This document may contain forward-looking statements concerning risks and uncertainties. These statements typically use forward-looking language such as “estimates,” “projected,” “expects,” “envisions,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose,” and variations or similar expressions (or their negative equivalents). These forward-looking statements are not guarantees of future performance, conditions, or results, and involve numerous known and unknown risks, uncertainties, assumptions, and other key factors—many beyond EUDA’s control—that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should not place undue reliance on forward-looking statements, which apply only as of the date this document is published. The Company does not undertake any obligation to update or revise any forward-looking statements, whether due to new information, future events, or otherwise, except as required by law.
Christensen Advisory
Christian Arnell
Phone: + 852 9040 0621
Email:
